In line with this finding, Ge et al. recently reported that in vitro BCL6 gene expression is regulated by direct CX-4945 target Ikaros, and that increased BCL6 expression in adult B-ALL patients is associated with inferior outcomes [35]. The gene discussed is BCL6; the disease is precursor B-cell acute lymphoblastic leukemia.